Gradientech: Funding, Investors & Team (Sep 2026)
Gradientech is a Swedish in vitro diagnostics company that supports the modern microbiology lab with cutting-edge solutions to facilitate the workflow with time-critical samples. Our product, QuickMIC®, is an ultra-rapid system for antibiotic susceptibility testing (AST) of positive blood culture samples from sepsis patients. QuickMIC® is a scalable system with each instrument analysing one sample against a tailored gram-negative antibiotic panel. MIC values are reported in as short as 2 hours, making it more rapid than any other diagnostic system for phenotypic AST. Gradientech’s technology combines microfluidics with live imaging to analyse bacterial responses on a linear antibiotic concentration gradient. The revolutionary technology delivers MIC values with unprecedented precision in record time.
Gradientech has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Oct 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gradientech Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Gradientech Funding Rounds
Gradientech Founders and Leadership Team
Contact details for the Gradientech team: 1 of 1 has an email address on file.
Start 14-day free trial →Gradientech Funding Compared to Other Biotechnology Startups
Gradientech's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gradientech in Biotechnology and Uppsala
Companies Similar to Gradientech
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Gradientech Funding FAQs
What does Gradientech do?
Gradientech is a Swedish in vitro diagnostics company that supports the modern microbiology lab with cutting-edge solutions to facilitate the workflow with time-critical samples. Our product, QuickMIC®, is an ultra-rapid system for antibiotic susceptibility testing (AST) of positive blood culture samples from sepsis patients. QuickMIC® is a scalable system with each instrument analysing one sample against a tailored gram-negative antibiotic panel. MIC values are reported in as short as 2 hours, making it more rapid than any other diagnostic system for phenotypic AST. Gradientech’s technology combines microfluidics with live imaging to analyse bacterial responses on a linear antibiotic concentration gradient. The revolutionary technology delivers MIC values with unprecedented precision in record time.
How much funding has Gradientech raised?
Gradientech has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Oct 2024.
When did Gradientech last raise funding?
Gradientech's most recent funding round on record is an undisclosed round of $3.0M, announced in Oct 2024.
Who founded Gradientech?
FundedIQ lists Sara Thorslund (Founder) at Gradientech.
Where is Gradientech headquartered?
Gradientech is based in Uppsala, Uppsala Lan, Sweden.
How many employees does Gradientech have?
Gradientech is in the 101-250 employee band.
How does Gradientech's funding compare to other Biotechnology startups?
Gradientech's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Gradientech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gradientech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.